Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029342
Filing Date
2019-08-06
Accepted
2019-08-06 16:10:47
Documents
83
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qtnt-10q_20190630.htm 10-Q 2117539
2 EX-31.1 qtnt-ex311_10.htm EX-31.1 16385
3 EX-31.2 qtnt-ex312_6.htm EX-31.2 16461
4 EX-32.1 qtnt-ex321_7.htm EX-32.1 5132
5 EX-32.2 qtnt-ex322_8.htm EX-32.2 5146
  Complete submission text file 0001564590-19-029342.txt   8681500

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT qtnt-20190630.xml EX-101.INS 2001245
7 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20190630.xsd EX-101.SCH 60142
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qtnt-20190630_cal.xml EX-101.CAL 95165
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qtnt-20190630_def.xml EX-101.DEF 197218
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20190630_lab.xml EX-101.LAB 485710
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20190630_pre.xml EX-101.PRE 397655
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-36415 | Film No.: 191002173
SIC: 2835 In Vitro & In Vivo Diagnostic Substances